# A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

> **NCT07628127** · PHASE1 · RECRUITING · sponsor: **Verdiva Bio Dev Limited** · enrollment: 336 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** VRB-103
- **OTHER:** Placebo
- **DRUG:** VRB-101

## Key facts

- **NCT ID:** NCT07628127
- **Lead sponsor:** Verdiva Bio Dev Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-06
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2026-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628127, "A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07628127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*